Bio-Key IntlBKYI
13F holders, Q1 2026 (March 31)9holders −5
3new positions
7sold out
$0.53avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Bio-Key Intl Inc. (BKYI) in their 13F filings, down 5 from Q4 2025. 3 opened new positions and 7 sold out. The largest holders were Geode Capital Management, LLC ($157K), Citigroup Inc. ($27K) and Vanguard Capital Management LLC ($18K).
- Company
- Bio-Key Intl Inc.
- CUSIP
- 09060C507
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $21K |
| Exits | 7 | $37K |
All 13F filers, Q4 2025 → Q1 2026: 336,781 shares bought and 79,064 shares sold, net +257,717 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | Add +504.3% | 295,431 | $157K |
| Citigroup Inc. | 0.00% | Add +457618.2% | 50,349 | $27K |
| Vanguard Capital Management LLC | 0.00% | — | 34,846 | $18K |
| Virtu Financial LLC | 0.00% | New | 20,713 | $11K |
| Susquehanna International Group, LLP | 0.00% | New | 17,191 | $9K |
| UBS Group AG | 0.00% | Reduce -63.6% | 5,558 | $3K |
| Morgan Stanley | 0.00% | New | 2,000 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.5% | 1,753 | $929 |
| SBI Securities Co., Ltd. | 0.00% | No change | 300 | $159 |
"% of holder's portfolio" is BKYI's weight in each manager's 13F, not the share of Bio-Key Intl Inc. the manager owns.